Invesco’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,997
Closed -$155K 3825
2025
Q3
$155K Sell
10,997
-1,112
-9% -$17.3K ﹤0.01% 3614
2025
Q2
$233K Buy
+12,109
New +$189K ﹤0.01% 3474
2025
Q1
Sell
-6,072
Closed -$101K 3802
2024
Q4
$101K Sell
6,072
-40
-0.7% -$499 ﹤0.01% 3622
2024
Q3
$62.1K Buy
6,112
+27
+0.4% +$803 ﹤0.01% 3667
2024
Q2
$351K Sell
6,085
-1,322
-18% -$64.8K ﹤0.01% 3437
2024
Q1
$247K Buy
7,407
+4,993
+207% +$253K ﹤0.01% 3581
2023
Q4
$196K Sell
2,414
-540
-18% -$43.9K ﹤0.01% 3573
2023
Q3
$482K Sell
2,954
-3,245
-52% -$766K ﹤0.01% 3218
2023
Q2
$2.03M Buy
6,199
+3,488
+129% +$1.06M ﹤0.01% 2623
2023
Q1
$748K Sell
2,711
-7,538
-74% -$2.77M ﹤0.01% 3048
2022
Q4
$3.97M Buy
10,249
+8,212
+403% +$2.32M ﹤0.01% 2363
2022
Q3
$487K Buy
2,037
+135
+7% +$36.1K ﹤0.01% 3259
2022
Q2
$424K Buy
1,902
+92
+5% +$39.6K ﹤0.01% 3410
2022
Q1
$1.23M Buy
1,810
+476
+36% +$286K ﹤0.01% 2982
2021
Q4
$923K Sell
1,334
-23
-2% -$17K ﹤0.01% 3102
2021
Q3
$1.01M Buy
1,357
+263
+24% +$179K ﹤0.01% 3103
2021
Q2
$820K Buy
+1,094
New +$836K ﹤0.01% 3211
2021
Q1
Sell
-2,454
Closed -$2.09M 3924
2020
Q4
$2.09M Buy
2,454
+121
+5% +$93.3K ﹤0.01% 2605
2020
Q3
$1.75M Buy
+2,333
New +$1.92M ﹤0.01% 2560

Other funds holding OM

Invesco's OM Position: Q4 2025 in Review

Invesco sold out of Outset Medical (OM) in Q4 2025, closing a stake of 10,997 shares — an estimated $155K sold.

Invesco first reported a position in OM in Q3 2020 and held it in 19 quarters. The position peaked at $3.97M in Q4 2022. 100 funds tracked by Wall St. Rank hold OM as of Q4 2025.

  • Invesco reported no remaining Outset Medical position as of Q4 2025 after selling out during the quarter.
  • Invesco sold 10,997 Outset Medical shares in Q4 2025, an estimated $155K.
  • Invesco first reported a position in Outset Medical in Q3 2020 and held it in 19 quarters.
  • Invesco's Outset Medical position peaked at $3.97M in Q4 2022.
  • 100 funds tracked by Wall St. Rank held Outset Medical as of Q4 2025.

Based on Invesco's 13F filing for Q4 2025, filed 19 Feb 2026.